#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy - Endpoints News

#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News

October 1, 2026

#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy Endpoints NewsThe Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What Kind WSJRegeneron weight-loss drug halves muscle loss in combination with Novo’s semaglutide in trial ReutersWeight-loss drug developers line up to tap lucrative market as competition heats up Reuters